Right-time Adaptive Particle Therapy Of canceR - Personalisation through anatomical plus biological adaptation

MSCA (Marie Skłodowska-Curie)HORIZON-TMA-MSCA-DNID: 101226720
EC Contribution
€45,091
Consortium Size
34 orgs
Start Year
2026
Summary

The RAPTORplus consortium gathers excellent research institutions, academic hospitals and non-academic particle therapy (PT) centres, industrial corporations and public organisations. It offers a platform for intercultural, interdisciplinary and inter-sectoral training and education of doctoral candidates (DCs) in the field of medical physics focussing on right-time adaptive PT. The assembled infrastructure and expertise from academia, clinic and industry is needed to address the challenges of personalised adaptive PT.PT is a precise form of radiotherapy with a growing number of centres treating patients. It targets localised cancers while sparing healthy tissue, but might deliver suboptimal doses in case of anatomical changes. To exploit the full potential of PT, fast and safe online treatment adaptations must be enabled and performed if beneficial, e.g. indicated by image-based biomarkers, biological models or other response data. The research projects conducted at academic and non-academic facilities will tackle (1) the efficient realisation of online-adaptive PT (OAPT), (2) the technological completion for broad and safe use of OAPT, and (3) a further treatment personalisation by biomarker-based adaptation. The network uses a multi-sectoral approach to ensure that the DCs develop scientific, clinical and practical industry-relevant skills. The holistic training programme includes in-person training camps, online trainings, project-specific secondments, training in tutoring, research communication, entrepreneurship and science policy, and opportunities to participate in international conferences and professional networks. RAPTORplus will train the next generation of research leaders, medical physicists and entrepreneurs to be aware of the necessity of right-time adaptive PT. They will drive innovation in the coming era of adaptive PT and improve cancer care through enduring international and cross-sectoral collaborations based on their transformative thinking.

Consortium (34)

🇩🇪 HELMHOLTZ-ZENTRUM DRESDEN-ROSSENDORF EVDE
coordinator
AARHUS UNIVERSITET
partner
🇳🇱 ACADEMISCH ZIEKENHUIS GRONINGENNL
partner
🇩🇪 BRAINLAB AGDE
partner
🇸🇮 COSYLAB LABORATORIJ ZA KONTROLNE SISTEME DDSI
partner
🇨🇭 EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICHCH
partner
🇳🇱 EUROPEAN FEDERATION OF ORGANISATIONS FOR MEDICAL PHYSICSNL
partner
🇧🇪 EUROPEAN SOCIETY FOR RADIOTHERAPY AND ONCOLOGYBE
partner
🇮🇹 FONDAZIONE CENTRO NAZIONALE DI ADROTERAPIA ONCOLOGICAIT
partner
🇩🇪 GSI HELMHOLTZZENTRUM FUR SCHWERIONENFORSCHUNG GMBHDE
partner
🇳🇴 HELSE BERGEN HFNO
partner
🇳🇴 HOGSKULEN PA VESTLANDETNO
partner
🇳🇱 HOLLAND PARTICLE THERAPY CENTRE BVNL
partner
🇧🇪 ION BEAM APPLICATIONS SABE
partner
🇮🇹 ISTITUTO NAZIONALE DI FISICA NUCLEAREIT
partner
🇧🇪 KATHOLIEKE UNIVERSITEIT LEUVENBE
partner
🇩🇪 KLINIKUM DER LUDWIG-MAXIMILIANS-UNIVERSITAT MUNCHENDE
partner
🇩🇪 LUDWIG-MAXIMILIANS-UNIVERSITAET MUENCHENDE
partner
🇦🇹 MEDIZINISCHE UNIVERSITAET WIENAT
partner
🇳🇴 NORGES TEKNISK-NATURVITENSKAPELIGE UNIVERSITET NTNUNO
partner
🇨🇭 Particle Therapy Co-Operative Group (PTCOG)CH
partner
🇨🇭 PAUL SCHERRER INSTITUTCH
partner
POLITECNICO DI MILANO
partner
🇸🇪 RAYSEARCH LABORATORIES AB (PUBL)SE
partner
🇩🇪 SIEMENS HEALTHINEERS AGDE
partner
🇸🇪 STOCKHOLMS UNIVERSITETSE
partner
🇩🇪 TECHNISCHE UNIVERSITAET DRESDENDE
partner
🇺🇸 THE GENERAL HOSPITAL CORPORATIONUS
partner
🇬🇧 THE UNIVERSITY OF MANCHESTERGB
partner
🇪🇸 UNIVERSIDAD DE NAVARRAES
partner
🇮🇹 UNIVERSITA DEGLI STUDI DI TORINOIT
partner
🇨🇭 UNIVERSITAET BERNCH
partner
🇩🇪 UNIVERSITATSKLINIKUM HEIDELBERGDE
partner
🇸🇮 UNIVERZA V LJUBLJANISI
partner